SAFC Supply Solutions Introduces New High-Quality Starting Materials for Oligo-Based Drugs |
 |
May 17, 2007 |
|
|
| |
|
St. Louis, MO - SAFC Supply Solutions, a business segment of SAFC and member of the Sigma-Aldrich group, (NASDAQ: SIAL), announces an extension to its range of starting materials for oligo-based drugs and will highlight new high-purity RNA Pharmadite™ amidites at the TIDES® Conference in Las Vegas, Nevada on May 20 - 23, 2007. This range of new material complements a cluster of new Proligo® Reagent introductions in the recent past.
High-quality amidites are the key contributors to final oligo purity, high synthesis effectiveness, compliance and cost optimization. SAFC's new RNA Pharmadite amidites, like the entire Pharmadite product line, are characterized through a highly-controlled impurity profile and possess exceptional overall purity and quality support - in compliance with EMEA requirements for Active Pharmaceutical Ingredient (API) starting materials. Their unprecedented purity specification of greater than or equal to 99% purity is achieved by a reverse phase HPLC process.
SAFC Supply Solutions is well known for its Proligo Reagents product line, comprising all key raw materials for the synthesis of oligonucleotides. The company focuses on high product quality and compliance to strengthen its position as a long-term material supplier to customers, partnering from early-stage drug development to late-phase commercial production.
SAFC Supply Solutions is a major global provider of raw materials and customized services for the pharmaceutical, biopharmaceutical, IVD diagnostics and Flavors & Fragrances sectors. A total supply chain capability embraces over 85,000 products - of which 45,000 are manufactured in-house. The business has facilities in the United States, Germany, Switzerland and the United Kingdom.
About SAFC:
SAFC is the custom manufacturing and services group within Sigma-Aldrich that focuses on high-purity inorganics for high technology applications, cell culture products and services for biopharmaceutical manufacturing, biochemical production and the manufacturing of complex, multi-step organic synthesis of APIs and key intermediates. SAFC has manufacturing facilities around the world dedicated to providing manufacturing services for companies requiring a reliable partner to produce their custom manufactured materials. SAFC has four operating segments SAFC Pharma, SAFC Supply Solutions, SAFC Biosciences, and SAFC Hitech, and had annual sales of nearly $500 million in 2006. SAFC is one of the world's 10 largest fine chemical businesses.
About Sigma-Aldrich:
Sigma-Aldrich is a leading Life Science and High Technology company. Our biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing. We have customers in life science companies, university and government institutions, hospitals and in industry. Over one million scientists and technologists use our products. Sigma-Aldrich operates in 36 countries and has 7,500 employees providing excellent service worldwide. We are committed to accelerating Customers' success through leadership in Life Science, High Technology and Service. For more information about Sigma-Aldrich, please visit our award-winning web site at sigma-aldrich.com.
Cautionary Statement:
This release contains forward-looking statements relating to future performance, goals, strategic actions and initiatives and similar intentions and beliefs. These statements involve assumptions regarding Company operations, investments and acquisitions and conditions in the markets the Company serves. Although the Company believes its expectations are based on reasonable assumptions, such statements are subject to risks and uncertainties, including, among others, certain economic, political and technological factors. Actual results could differ materially from those stated or implied in this news release, due to, but not limited to, such factors as (1) changes in pricing and the competitive environment, (2) fluctuations in foreign currency exchange rates, (3) dependence on uninterrupted manufacturing operations, (4) changes in the regulatory environment in which the Company operates, (5) changes in research funding and the success of research and development activities, (6) the ability to maintain adequate quality standards, (7) reliance on third party package delivery services, (8) the impact of acquisitions and success in integrating and obtaining projected results from the acquisitions, and (9) other changes in the business environment in which the Company operates. The Company does not undertake any obligation to update these forward-looking statements.
Forward Inquiries To:
Dr. Frank Wicks
President, SAFC
+ (314).286.8008 |
Media Inquiries:
Mr. Richard Kerns
Northern Exposure
+44.161.728.5880 |
|
|
|
